Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

480.75 +12.37 (+2.64%)

Streaming Delayed Price Updated: 12:16 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9

...

69 70 Next >

Inspire Medical Systems, Ichor Holdings, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

August 05, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 05, 2025

Via Benzinga

Why Palantir Technologies Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket ↗

August 05, 2025

Via Benzinga

Earnings Scheduled For August 4, 2025 ↗

August 04, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 04, 2025

Via Benzinga

Vertex Pharmaceuticals Stock Dives After Q2 Earnings, Phase 2 Results For VX-993 ↗

August 04, 2025

Vertex Pharmaceuticals announces financial results for the second quarter after the market close on Monday. Here's a rundown of the report.

Via Benzinga

Which stocks are moving after the closing bell on Monday? ↗

August 04, 2025

After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Stock Plummets 13% After Discontinuing VX-993 Despite Q2 Earnings Beat ↗

August 04, 2025

Vertex Q2 2025 earnings beat estimates, but stock dropped 13% after discontinuing acute pain drug VX-993. Focus remains on CF and other key programs.

Via Chartmill

Topics Earnings

Vertex Crashes After Pain Drug Flop Outweighs Second-Quarter Beat ↗

August 04, 2025

Vertex stock crashed late Monday after the company said it wouldn't advance a next-generation pain drug into more testing.

Via Investor's Business Daily

Topics ETFs

Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q2 Sales Beat Estimates But Stock Drops 13.5%

August 04, 2025

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 12.1% year on year to $2.96 billion. The company expects the full...

Via StockStory

Topics Earnings

Vertex Reports Second Quarter 2025 Financial Results

August 04, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain

August 04, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Vertex Pharmaceuticals Likely To Report Q2 Profit; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗

August 04, 2025

Via Benzinga

Stock Market Today: US Stocks Likely To Open Higher Despite Weak Jobs Report—Palantir, Vertex Pharma In Focus ↗

August 04, 2025

US stock futures are up on Monday after ending Friday deep in the red, following a disappointing jobs report by Bureau of Labor Statistics.

Via Benzinga

What To Expect From Vertex Pharmaceuticals’s (VRTX) Q2 Earnings

August 02, 2025

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting earnings this Monday after the bell. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence Economy World Trade

3 Unstoppable Stocks to Buy in August ↗

August 02, 2025

Here are hot stocks to buy in a hot month.

Via The Motley Fool

Topics Intellectual Property

Here's How Much $1000 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth Today ↗

August 01, 2025

Via Benzinga

Examining the Future: Vertex Pharmaceuticals's Earnings Outlook ↗

August 01, 2025

Via Benzinga

2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now ↗

August 01, 2025

These growth stocks have plenty of room to run.

Via The Motley Fool

The 3 Things That Matter for Vertex Pharmaceuticals Now ↗

July 28, 2025

Some of these developments could improve the company's prospects.

Via The Motley Fool

3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial Results ↗

July 22, 2025

Via The Motley Fool

3 Monster Stocks in the Making to Buy Right Now ↗

July 21, 2025

Via The Motley Fool

3 Top Growth Stocks to Buy in the Second Half of 2025 ↗

July 19, 2025

Via The Motley Fool

Topics Artificial Intelligence

Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today ↗

July 18, 2025

Via Benzinga

3 Cash-Burning Stocks Walking a Fine Line

July 15, 2025

Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even...

Via StockStory

Topics Bankruptcy Economy

Vertex Named a Premier, Inc. Breakthroughs Innovation Celebration Winner for JOURNAVX™, a First-in-Class Non-Opioid Treatment for Adults With Moderate-to-Severe Acute Pain

July 14, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

My 3 Top Stocks to Buy in a Market That's Highly Volatile (Again) ↗

July 14, 2025

Via The Motley Fool

Topics Artificial Intelligence Energy World Trade

The Best Stocks to Invest $1,000 in Right Now ↗

July 12, 2025

Via The Motley Fool

Topics Artificial Intelligence

10 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗

July 12, 2025

With just a little bit of a deeper look, these businesses are positioned for long-term growth.

Via The Motley Fool

Motley Fool Co-Founder David Gardner Reviews Stock Picks ↗

July 11, 2025

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

69 70 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.